Introduction 7 4
Mitochondrial dysfunction has been described as a common hallmark of neurological amyloid precursor protein (APP) and Aβ deposits within the brain 2 , suggesting a link dementia. However, due to the embryonic lethality observed in complete PITRM1 1 0 7 knockout mice, the exact role of PITRM1 in brain homeostasis and disease could not 1 0 8 be studied 2 . Since PITRM1 is involved in the degradation of MTS, as well as Aβ gene was normalized to the housekeeping gene ribosomal protein large P0 (Rplp0).
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Fold-changes in gene expression were calculated using the 2 -DDCT method, based on 2 4 2 biological reference samples and housekeeping genes for normalization. #15440-1-AP); mouse anti-tau (1:1000, HT7, Thermofisher #MN1000); mouse anti 2 7 1 phospho-tau PHF-6 (Thr231) (1:1000, Thermofisher #35-5200); mouse anti-β-Actin (1:20000, Sigma Aldrich #A5441); mouse anti-VDAC1 (1:1000, Santa Cruz Biotechnologies #sc-390996). (EMD, Millipore) for 4 h. LC3-II and LC-I levels were quantified by densitometry and 2 7 8 normalized to β -actin. LC3 flux was quantified by dividing the levels of LC3-II after 2 7 9 treatment with lysosomal inhibitor for 4h, by the levels of LC3-II without treatment. tubulin positive cells was quantified with the "analyse particles" plug-in in ImageJ 2 9 4 (NIH). Caspase 3 was quantified with mean fluorescence intensity in Image J (NIH).
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Quantification was carried out on, at least, 50 cells per condition, from three 2 9 6 independent experiments. The LDH assay (Promega) was performed as per the manufacturer's instructions. For amyloid-beta species measurement in iPSC-cortical neurons, 10^6 cells were 3 0 3 plated into a one well of 12-well plate and cell supernatant was collected after 5 days, Individual cerebral organoids were homogenized in ice-cold RIPA buffer containing 3 2 6
protease and phosphatase inhibitors (Roche), following centrifugation at 14.000 rpm and 4°C for 10min. The protein concentration of the supernatant was determined by using ELISA assays (both Invitrogen, KHB0041 and KHO0631, respectively)
according to manufacturer's instructions. In order to overcome the limitation of the embryonic lethality previously observed in reduced in PITRM1 -/neurons compared to isogenic PITRM1 +/+ neurons (Fig. 1C ).
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However, mitochondrial reactive oxygen species (mtROS) were not significantly Complex II respiratory chain complex subunits in PITRM1 -/neurons ( Fig. 1F , G).
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However, no significant difference for the levels of all other respiratory chain complex Mitochondrial stress response has been identified as a common signature in several 3 7 8 neurodegenerative as well primary mitochondrial diseases [16] [17] [18] [19] . Thus, we examined 3 7 9
the expression levels of genes involved in mitochondrial unfolded protein response 3 8 0 (UPR mt ) and, more generally, in the mitochondrial integrated stress response was significantly upregulated in PITRM1 -/neurons compared to controls ( Fig. 2A ). In chaperones HSPA9 and HSP60, and the mitochondrial protease LONP1 (Fig. 2B ).
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These data indicate that the accumulation of MTS, due to PITRM1 deficiency, leads To examine the impact of PITRM1 activity on Aβ pathology, we first assessed the were not detected in mitochondrial extracts from PITRM1 deficient neurons. Next, we metabolism. Since UPR mt may have an impact on ubiquitin-dependent protein 4 1 9 turnover 23 , we examined the levels of ubiquitinated proteins by Western blot. We To further investigate the mechanisms of PITRM1 neurotoxicity in a model that better cortical layering characteristics ( Fig. 4A and Supplementary Fig. 2A ). Next, we hyperphosphorylation in 2-months old PITRM1 -/cerebral organoids (Fig. 4B-E) . Furthermore, immunoassay measurements showed a higher Aβ40, Aβ42 and 4 3 6
Aβ42/Aβ40 ratio in PITRM1 -/cerebral organoids compared to controls 4 3 7
( Supplementary Fig. 2B ). Similarly, immunofluorescence staining showed increased organoids display increased levels of ubiquitinated proteins (Fig 4J, K) . Thioflavin T 4 4 9 positive aggregates were detected in cerebral organoids generated from PITRM1 -/-
iPSCs, indicating that protein deposits are organized into amyloid-like aggregates, 4 5 1 similar to the ones observed in AD plaques ( Supplementary Fig. 2E ). Next, we Given that UPR mt can extend lifespan in a variety of organisms 24-27 , we asked 4 6 1 whether the induction of UPR mt observed in PITRM1 -/cerebral organoids could act as 4 6 2 14 a protective mechanism against defects of mitochondrial protein maturation and Aβ treated cerebral organoids showed higher APP and phospho-tau levels compared to 4 6 7 controls ( Fig. 5A-C) . Remarkably, the effect was similar in both PITRM1 +/+ and 4 6 8 PITRM1 -/organoids ( Fig. 5A-C) . In parallel, ISRIB treatment significantly increased 4 6 9
the Aβ42/Aβ40 ratio (Fig. 5D ) in both PITRM1 +/+ and PITRM1 -/organoids. Interestingly, ISRIB-treated cerebral organoids also showed an increase of 4 7 1 mitochondrial DNA, suggesting that inhibition of UPR mt leads to a decrease of 4 7 2 mitochondrial clearance (Fig. 5E ). Since defects in mitophagy have been shown to contribute to AD 29 and ISRIB- the exact mechanisms of PITRM1 in brain function and disease could not be entirely 5 0 6 studied. To address these quetions, we have generated a novel human stem cell- methods coupled with a highly sensitive immunoassay, we were unable to detect Aβ 5 1 8 peptides in mitochondrial extracts from PITRM1 deficient cortical neurons. We cannot exclude the accumulation of low amount of Aβ peptides within the 5 2 0 mitochondria, below the detection limit of this study. However, PITRM1 -/neurons did 5 2 1 not show an increase in mitochondrial ROS production or defects in oxidative 5 2 2 phosphorylation, which have been shown to be a direct effect of the accumulation of 5 2 3
Aβ within mitochondria 33, 34 . Our data suggests that MTS toxicity and mitochondrial processes is unclear. The UPR mt has been proposed to be a double edge sword, showed a significant increase of APP levels, increased Aβ42/Aβ40 ratio, and tau 5 5 2
hyperphosphorylation. Based on these data, we propose that PITRM1-related 5 5 3
induction of UPR mt is a protective mechanism against proteotoxic stress both at the into consideration for therapeutic decisions.
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Even though UPR mt was activated in both 2D and 3D PITRM1 KO models, only and increase of mitochondrial protein ubiquitination suggest that PITRM1 deficiency 5 7 8 leads to increased mitochondrial clearance. It is known that defects in PITRM1 mitochondrial clearance in our model. Interestingly, mitochondrial stress response and mitophagy transcripts have been 5 9 0
found to be upregulated in mild cognitive impairment as well as in mild and moderate mitophagy is able to rescue AD-related pathology in different AD model systems 29 .
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In line with this finding, we show that stimulating mitophagy with NMN, a NAD+ 5 9 5
booster, significantly improves mitochondrial clearance, with a reduction of 5 9 6
Aβ42/Aβ40 ratio and tau hyperphosphorylation. On the contrary, inhibition of UPR mt 5 9 7
with ISRIB led to decreased mitochondrial clearance and aggravation of Aβ and tau In conclusion, we report a novel cellular model of human PITRM1 deficiency that p<0.001, two-tailed t test, n=3). 
